Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q3 2025 Earnings Call Transcript November 5, 2025
Jazz Pharmaceuticals plc beats earnings expectations. Reported EPS is $8.13, expectations were $5.74.
Operator: Good day, and thank you for standing by. Welcome to the Jazz Pharmaceuticals 2025 Third Quarter Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your first speaker today, Jack Spinks,...
